Nuwellis Reports ~50% Of U.S. Revenue In 2025

Nuwellis, Inc. (Nasdaq: NUWE) reported that its pediatric category has become the largest and fastest-growing segment, accounting for approximately 50% of total U.S. revenue in 2025. The company focuses on providing solutions for patients with cardiorenal conditions.